Orris

A 25-year-old male presented with fever, body ache & retro-orbital pain for 5 days. On examination, skin rashes were found over the whole body, a) What is your probable diagnosis? b) How would you proceed to confirm the diagnosis in such a case in the laboratory? c) How to prevent such a condition?

Reading File
Finding Sources
Finding Sources
Searching Images

dengue fever skin rash maculopapular

This clinical photograph displays a patient's abdomen and arm presenting a generalized, confluent erythematous rash, a characteristic cutaneous manifestation of Dengue Fever. The exanthem is marked by widespread, intense redness resulting from capillary dilatation and coalesced maculopapular lesions. A diagnostic hallmark visible here is the presence of 'islands of sparing'—small, rounded, or oval-shaped patches of normal-colored skin scattered throughout the erythematous background, often described as 'white islands in a sea of red'. These spared areas are randomly distributed across the affected trunk and limbs. The image serves as a key educational reference for recognizing the secondary rash phase of Dengue viral infection, typically occurring 3 to 6 days after the onset of fever. The visual presentation is essential for clinical diagnosis and differentiation from other viral exanthems, highlighting the specific immunologic response patterns seen in Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF).

This clinical photograph displays a patient's abdomen and arm presenting a generalized, confluent erythematous rash, a characteristic cutaneous manifestation of Dengue Fever. The exanthem is marked by widespread, intense redness resulting from capillary dilatation and coalesced maculopapular lesions. A diagnostic hallmark visible here is the presence of 'islands of sparing'—small, rounded, or oval-shaped patches of normal-colored skin scattered throughout the erythematous background, often described as 'white islands in a sea of red'. These spared areas are randomly distributed across the affected trunk and limbs. The image serves as a key educational reference for recognizing the secondary rash phase of Dengue viral infection, typically occurring 3 to 6 days after the onset of fever. The visual presentation is essential for clinical diagnosis and differentiation from other viral exanthems, highlighting the specific immunologic response patterns seen in Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF).

This is a high-resolution clinical photograph of the lower leg illustrating a diffuse febrile maculopapular eruption in the setting of suspected dengue fever. The image shows a broad area of coalescing erythema with patches of preserved or pale skin appearing as white islands within the red background, often described as white islands in a sea of red. The rash spans a substantial portion of the exposed leg surface and appears non-vesicular, with fine surface capillary blanching evident under light. There is no visible mucosal involvement or purpura in this view. The patient reports a 5-day history of fever, severe myalgias/body aches, and backache, compatible with the febrile phase of dengue. Morphology is consistent with a maculopapular eruption commonly seen in flavivirus infections; pattern may be confluent on extremities with interspersed hypopigmented or ischemic-looking islands. In the clinical context of dengue, such eruptions typically appear during the acute febrile period and may fade with defervescence. This image is valuable for dermatology and infectious disease education, aiding recognition of dengue-associated rash patterns, differentiation from other viral exanthems ( chikungunya, Zika ), and consideration of differential diagnoses and appropriate laboratory testing. NS1 antigen, RT-PCR, serology. It supports teaching on cutaneous manifestations of dengue.

This is a high-resolution clinical photograph of the lower leg illustrating a diffuse febrile maculopapular eruption in the setting of suspected dengue fever. The image shows a broad area of coalescing erythema with patches of preserved or pale skin appearing as white islands within the red background, often described as white islands in a sea of red. The rash spans a substantial portion of the exposed leg surface and appears non-vesicular, with fine surface capillary blanching evident under light. There is no visible mucosal involvement or purpura in this view. The patient reports a 5-day history of fever, severe myalgias/body aches, and backache, compatible with the febrile phase of dengue. Morphology is consistent with a maculopapular eruption commonly seen in flavivirus infections; pattern may be confluent on extremities with interspersed hypopigmented or ischemic-looking islands. In the clinical context of dengue, such eruptions typically appear during the acute febrile period and may fade with defervescence. This image is valuable for dermatology and infectious disease education, aiding recognition of dengue-associated rash patterns, differentiation from other viral exanthems ( chikungunya, Zika ), and consideration of differential diagnoses and appropriate laboratory testing. NS1 antigen, RT-PCR, serology. It supports teaching on cutaneous manifestations of dengue.

A series of three clinical photographs demonstrating cutaneous manifestations in a patient with dengue fever. (a) Right upper arm showing confluent, blanchable erythema with a diffuse distribution. (b) Anterior trunk (abdomen and chest) displaying a patchy, mottled erythematous rash interspersed with areas of normal skin tone, characteristic of the 'islands of white in a sea of red' pattern often seen in viral exanthems. (c) Lower limbs showing localized, more intense erythema focused around the knees and pretibial regions. The visual findings illustrate the secondary maculopapular rash typical of the recovery or late febrile phase of dengue virus infection. These images serve as an educational resource for identifying the clinical presentation of viral hemorrhagic fever rashes and their variable morphology across different anatomical regions, including the trunk, extremities, and periarticular areas.

A series of three clinical photographs demonstrating cutaneous manifestations in a patient with dengue fever. (a) Right upper arm showing confluent, blanchable erythema with a diffuse distribution. (b) Anterior trunk (abdomen and chest) displaying a patchy, mottled erythematous rash interspersed with areas of normal skin tone, characteristic of the 'islands of white in a sea of red' pattern often seen in viral exanthems. (c) Lower limbs showing localized, more intense erythema focused around the knees and pretibial regions. The visual findings illustrate the secondary maculopapular rash typical of the recovery or late febrile phase of dengue virus infection. These images serve as an educational resource for identifying the clinical presentation of viral hemorrhagic fever rashes and their variable morphology across different anatomical regions, including the trunk, extremities, and periarticular areas.

Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information to construct a complete, well-structured answer. Here it is:

Probable Diagnosis: Dengue Fever (Classical Dengue / "Breakbone Fever")

The triad of fever + body ache/myalgia + retro-orbital pain + widespread skin rash in a young male is the hallmark presentation of classical dengue fever. The patient meets the WHO probable case definition perfectly.
Etiology: Dengue virus (a Flavivirus), serotypes 1-4. Vector: Aedes aegypti mosquito (daytime biter). Incubation period: 3-14 days (commonly 5-6 days).

a) Probable Diagnosis

Classical Dengue Fever - supported by:
FeatureThis Patient
Acute febrile illness (5 days)✓
Retro-orbital pain (on eye movement/pressure)✓
Myalgia / body ache ("breakbone fever")✓
Widespread skin rash✓
Age group (healthy young adult)✓ (highest risk group)
The rash in dengue classically appears on day 3-4 as a maculopapular or scarlatiniform eruption beginning on the chest/trunk and spreading to extremities, with pathognomonic "white islands in a sea of red" - areas of normal skin interspersed in a confluent erythema.
Dengue fever rash - islands of white in a sea of red
Classic dengue rash showing confluent erythema with "islands of sparing" (white islands in a sea of red)
Dengue maculopapular rash on lower limb
Dengue maculopapular eruption on lower limb - coalescing erythema with pale islands
Differential diagnoses to consider: Chikungunya (prominent joint pain), Zika virus, measles, typhus, scarlet fever.

b) Laboratory Confirmation

The choice of test depends on the day of illness at the time of sample collection. Since this patient is on day 5, both virological and serological testing should be done on a single serum sample.

Direct Virological Tests (Days 1-7, during viremic phase)

1. NS1 Antigen Detection (ELISA or Rapid Test)
  • Detects non-structural protein 1 (NS1) of dengue virus
  • Positive from day 1 of fever up to day 6
  • Commercial rapid kits give results in minutes; ELISA takes ~1 day
  • Does not differentiate between serotypes
  • Best early-phase test - can detect cases from day 1
2. RT-PCR (Reverse Transcriptase - Polymerase Chain Reaction)
  • Detects viral RNA genome (positive days 1-7 of illness)
  • High specificity; identifies serotype
  • Turnaround: 1-2 days
  • Specimen: acute phase serum (days 1-5)
3. Virus Isolation
  • Gold standard but impractical - takes 1 week or more
  • Specimen: acute serum/plasma, buffy coat (within first 6 days)
  • Done only in reference/research labs

Serological Tests (Best after Day 5)

4. IgM Capture ELISA (MAC-ELISA) - Most important bedside/lab test
  • IgM detectable from day 3-5 of illness onset
  • 99% of patients have IgM by day 10
  • IgM peaks at 2 weeks, then declines over 2-3 months
  • Can cross-react with Zika and other flaviviruses
  • Can detect both primary and secondary infections
5. IgG ELISA / Haemagglutination Inhibition (HIA)
  • IgG persists for life
  • A fourfold rise in IgG titers between acute (days 1-5) and convalescent sera (day >15) confirms recent infection
  • HIA titre ≥1:1280 on single sample is supportive
6. IgM/IgG Ratio
  • Distinguishes primary infection (high IgM:IgG ratio) from secondary infection (high IgG, lower IgM)

Haematological Parameters (Mandatory Monitoring)

  • Complete Blood Count (CBC): Leukopenia (WBC ≤5000/mm³) and thrombocytopenia (platelets <150,000/mm³) strongly support dengue
  • Haematocrit: Rising haematocrit (≥5-10%) suggests plasma leakage - flags progression to DHF
  • Tourniquet test (Rumple-Leede test): ≥20 petechiae per 2.5 cm² is positive

Summary Table (Day of Illness)

Days of FeverRecommended TestMethodTime to Result
Day 1-5NS1 AntigenRapid kit / ELISAMinutes / 1 day
Day 1-7RT-PCRMolecular1-2 days
Day 5+IgM ELISASerology1-2 days
Day 1-5 + Day 15-21IgG seroconversionELISA / HIA1-2 days
Practical approach for this patient (day 5): Collect a single serum sample and test NS1 antigen + IgM antibody simultaneously - this combination identifies ≥90% of primary and secondary dengue cases.
  • Park's Textbook of Preventive and Social Medicine, p. 292-294
  • Red Book 2021, Report of the Committee on Infectious Diseases, p. 522-523

c) Prevention

Prevention works at three levels: host protection, vector control, and vaccination.

1. Personal Protection (Host)

  • Wear full-sleeve clothing (shirts and trousers) during peak mosquito activity hours (dawn and dusk)
  • Use mosquito repellents (creams, liquids, coils, mats containing DEET or picaridin)
  • Use bed nets (especially for infants and children sleeping during daytime, when Aedes is active)
  • Isolate febrile patients under bed nets during the first few days of illness to prevent mosquito-to-human transmission

2. Vector Control (Aedes aegypti elimination)

Aedes breeds in clean, stagnant water in and around houses - targeting its breeding sites is the most effective strategy.
Source Reduction (Anti-larval measures):
  • Empty, clean, or cover all water storage containers weekly ("weekly dry day")
  • Remove or overturn items that collect rainwater (tyres, flower pots, coconut shells, discarded containers)
  • Manage roof tops, porticos, and sunshades that collect water
  • Properly cover overhead tanks and water drums
Chemical control:
  • Larviciding: Temephos (Abate) in water containers that cannot be emptied
  • Adulticiding (fogging): Pyrethroid sprays during outbreaks to kill adult mosquitoes (malathion, deltamethrin)
Biological control:
  • Introduction of Bacillus thuringiensis israelensis (Bti) - a larvicide
  • Larvivorous fish (Gambusia, Poecilia) in large water bodies

3. Vaccination

CYD-TDV (Dengvaxia - Sanofi Pasteur): The first licensed dengue vaccine.
  • Tetravalent, live attenuated vaccine against all 4 serotypes (DENV 1-4)
  • Schedule: 3 injections of 0.5 ml subcutaneously, at 6-month intervals
  • Indicated for individuals 9-45 years living in dengue-endemic areas
  • Recommended only for seropositive individuals (prior dengue exposure) - risk of severe disease in seronegative vaccinees
  • Contraindicated in: immunocompromised individuals, HIV infection, pregnant/breastfeeding women

4. Surveillance and Public Health Measures

  • Early case notification and reporting to health authorities
  • Entomological surveillance (monitoring Aedes density)
  • Laboratory confirmation at sentinel surveillance hospitals
  • IEC (Information, Education, and Communication) campaigns for community awareness
  • Inter-sectoral coordination (urban development, education, transport)
  • Park's Textbook of Preventive and Social Medicine, p. 298-299
Key takeaway: This patient's presentation is dengue until proven otherwise. At day 5 of illness, send serum urgently for NS1 antigen + IgM ELISA, monitor CBC and haematocrit daily, give paracetamol only (avoid NSAIDs and aspirin - bleeding risk), encourage oral hydration, and watch for warning signs of progression to Dengue Haemorrhagic Fever (abdominal pain, persistent vomiting, bleeding, rapid deterioration of clinical state around the time of defervescence).
This is a shared conversation. Sign in to Orris to start your own chat.